Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yervoy and Adoptive T Cell Transfer in Metastatic Melanoma
NCT01988077Phase 2Terminated
- Sponsor
- Sheba Medical Center
- Start
- Oct 2013
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ipilimumab in melanoma, sponsored by Sheba Medical Center. Started Oct 2013; status: terminated.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01988077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988077.